Mar 19, 2018 11:00 am UTC| Business
CARMIEL, Israel, March 19, 2018 -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins...
Mar 19, 2018 11:00 am UTC| Business
Company to host webcast and conference call on Tuesday, March 20, 2018 at 8 am ET Management to discuss recent data and progress on development plans WALTHAM, Mass., March 19, 2018 -- Eloxx Pharmaceuticals, Inc....
M2 Compliance® to Sponsor the 28th Annual Oppenheimer Healthcare Conference
Mar 19, 2018 11:00 am UTC| Business
Los Angeles, CA, March 19, 2018 -- M2 Compliance® ("M2"), www.m2compliance.com, a world-leading filing agent registered with the Securities and Exchange Commission and full-service provider of EDGAR, XBRL, Inline XBRL...
Stifel Completes Acquisition of Ziegler Wealth Management
Mar 19, 2018 11:00 am UTC| Business
ST. LOUIS, March 19, 2018 -- Stifel Financial Corp. (NYSE:SF) today announced that it has completed the acquisition of Ziegler Wealth Management. “We are excited to welcome the team from Ziegler to our wealth...
First Majestic Renews Share Repurchase Program
Mar 19, 2018 11:00 am UTC| Business
VANCOUVER, British Columbia, March 19, 2018 -- First Majestic Silver Corp. (“First Majestic” or the “Company”) announces that its board of directors has approved the extension of its share repurchase program (the “Share...
Mar 19, 2018 11:00 am UTC| Business
RANCHO CORDOVA, Calif., March 19, 2018 -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the...
Axsome Therapeutics to Present at 17th Annual Needham Healthcare Conference
Mar 19, 2018 11:00 am UTC| Business
NEW YORK, March 19, 2018 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced...